Tabula Rasa HealthCare Inc Stock News

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.

Investors need to pay close attention to Tabula Rasa HealthCare (TRHC) stock based on the movements in the options market lately.

Tabula Rasa Healthcare (TRHC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several

Tabula Rasa Healthcare (TRHC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several

Goldman Sachs boosted the price target for Cisco Systems, Inc. (NASDAQ: CSCO) from $45 to $50. Cisco shares rose 5.1% to $49.02 in pre-market trading. Barclays raised the price target on The Progres

The mean of analysts' price targets for Tabula Rasa Healthcare (TRHC) points to a 79.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC ) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Kevin Dill - Corporate Counsel Calvin Knowlton - Founder, Chairman and Chief

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3,300% and 5.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3,300% and 5.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

After losing some value lately, a hammer chart pattern has been formed for Tabula Rasa Healthcare (TRHC), indicating that the stock has found support. This, combined with an upward trend in earnings e

10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tabula Rasa Healthcare (TRHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Nasdaq Composite jumped around 4% on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around

Tabula Rasa Healthcare (TRHC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several

US crude oil futures traded higher by around 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concer